Disease/Infection News

RSS

CD4+ T-cell count may not be helpful to assess ART response in HTLV-1/HIV co-infected patients

The authors compared the CD4+ T-cell counts and HIV-1 RNA viral loads of 383 patients who were either mono-infected with HIV or co-infected with HTLV-1/HIV.

17 Mar 2017

Biologists discover secondary set of odor sensors in malaria mosquitoes

Biologists who study the malaria mosquito's 'nose' have found that it contains a secondary set of odor sensors that seem to be specially tuned to detect humans. The discovery could aid efforts to figure out how the insects target humans and develop a preference for them.

17 Mar 2017

The Government of Somalia launches first oral cholera vaccination campaign

The Government of Somalia has launched an oral cholera vaccination (OCV) campaign today with the support of WHO, targeting over 450 000 people in 7 high-risk areas around the country.

17 Mar 2017

Canadian scientists join international battle against Zika virus

The spread of the Zika virus, which can cause devastating birth defects, has become a pressing public health issue in many countries. To this day, there is no vaccine to prevent and no medicine to treat Zika virus infections.

16 Mar 2017

Empathy of sick people may be crucial to ending infectious disease outbreaks

A little empathy can go a long way toward ending infectious disease outbreaks. That's a conclusion from researchers at the Georgia Institute of Technology, who used a networked variation of game theory to study how individual behavior during an outbreak of influenza - or other illness - affects the progress of the disease, including how rapidly the outbreak dies out.

16 Mar 2017

Researchers awarded CIHR grant to investigate how Zika virus changes host cells during infection

For more than a year, Tom Hobman and his research team have devoted most of their waking hours to a headlong pursuit of knowledge about the Zika virus.

16 Mar 2017

Research shows how Ebola viral proteins packaged in exosomes affect immune cells

Cells infected by the deadly Ebola virus may release viral proteins such as VP40 packaged in exosomes, which, as new research indicates, can affect immune cells throughout the body impairing their ability to combat the infection and to seek out and destroy hidden virus.

16 Mar 2017

Study shows how mutations allow HCV to elude immune responses and vaccines

Unlike its viral cousins hepatitis A and B, hepatitis C virus (HCV) has eluded the development of a vaccine and infected more than 170 million people worldwide.

16 Mar 2017

Research findings advance development of HIV vaccines that induce broadly neutralizing antibodies

A Duke Health-led research team has described both the pathway of HIV protective antibody development and a synthetic HIV outer envelope mimic that has the potential to induce the antibodies with vaccination.

16 Mar 2017

New class of membrane-busting compounds can combat MRSA skin infections in mice

Public health officials are increasingly concerned over methicillin-resistant Staphylococcus aureus (MRSA). The bacteria have developed resistance to a number of treatments, even antibiotics of last resort in some cases.

15 Mar 2017

Bacterial cell counting and sizing using the Multisizer

In this interview, Dr. Rich Jones introduces bacterial cell counting and an example of when the Multisizer 4e from Beckman Coulter has been used for this application.

From Beckman Coulter Life Sciences - Particle Counting and Characterization 15 Mar 2017

Researchers devise new way of creating common anti-malarial medication

Researchers at Cardiff University have devised a new way of creating a drug commonly used as the first line of defence against malaria around the world.

15 Mar 2017

Study: Investigational Ebola vaccine regimen induced immune response that persisted for one year

A two-vaccine regimen intended to protect against Ebola virus disease induced an immune response that persisted for approximately one year in healthy adult volunteers, according to results from a Phase 1 clinical trial published in the March 14th issue of the Journal of the American Medical Association.

15 Mar 2017

New study examines immune responses to Ebola vaccines at one year after immunization

Immune responses to Ebola vaccines at one year after vaccination are examined in a new study appearing in the March 14 issue of JAMA.

14 Mar 2017

New method can precisely track replication of yellow fever virus in host immune cells

Researchers from Princeton University's Department of Molecular Biology have developed a new method that can precisely track the replication of yellow fever virus in individual host immune cells.

14 Mar 2017

Pill form of C-diff treatment could be effective, easier for patients and physicians, study shows

Frozen and freeze-dried products for Fecal Microbiota Transplantation are nearly as effective as fresh product at treating patients with Clostridium difficile infection, according to researchers at The University of Texas Health Science Center at Houston School of Public Health and Kelsey Research Foundation.

14 Mar 2017

Study finds vaccines to be successful in preventing pandemic flu

Vaccines are successful in preventing pandemic flu and reducing the number of patients hospitalised as a result of the illness, a study led by academics at The University of Nottingham has found.

13 Mar 2017

Pre-existing immunity to dengue virus modulates T cell response to Zika infection

Although Zika and dengue are considered different virus "species," they are so closely related that the immune system treats Zika just like another version of dengue, report researchers at La Jolla Institute for Allergy and Immunology.

13 Mar 2017

Georgia State professor receives five-year $4.1 million federal grant to develop drug targeting Ebola virus

Dr. Christopher Basler, a professor in the Institute for Biomedical Sciences at Georgia State University, director of the university's Center for Microbial Pathogenesis and a Georgia Research Alliance Eminent Scholar in Microbial Pathogenesis, has received a five-year, $4.1 million federal grant to develop a drug targeting Ebola virus.

13 Mar 2017

UCL scientists develop way to use MRI scans for identifying HIV in the brain

Scientists at UCL have developed a way to use MRI scans to help identify when HIV is persisting in the brain despite effective drug treatment.

13 Mar 2017

Disease/Infection News

CD4+ T-cell count may not be helpful to assess ART response in HTLV-1/HIV co-infected patients

Biologists discover secondary set of odor sensors in malaria mosquitoes

The Government of Somalia launches first oral cholera vaccination campaign

Canadian scientists join international battle against Zika virus

Empathy of sick people may be crucial to ending infectious disease outbreaks

Researchers awarded CIHR grant to investigate how Zika virus changes host cells during infection

Research shows how Ebola viral proteins packaged in exosomes affect immune cells

Study shows how mutations allow HCV to elude immune responses and vaccines

Research findings advance development of HIV vaccines that induce broadly neutralizing antibodies

New class of membrane-busting compounds can combat MRSA skin infections in mice

Bacterial cell counting and sizing using the Multisizer

Researchers devise new way of creating common anti-malarial medication

Study: Investigational Ebola vaccine regimen induced immune response that persisted for one year

New study examines immune responses to Ebola vaccines at one year after immunization

New method can precisely track replication of yellow fever virus in host immune cells

Pill form of C-diff treatment could be effective, easier for patients and physicians, study shows

Study finds vaccines to be successful in preventing pandemic flu

Pre-existing immunity to dengue virus modulates T cell response to Zika infection

Georgia State professor receives five-year $4.1 million federal grant to develop drug targeting Ebola virus

UCL scientists develop way to use MRI scans for identifying HIV in the brain

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News